Prothena Corp Public PRTA
NASDAQ PRTA
$9.78 +0.18 (+1.87%)
As of: Sep 4, 2026 · 2:20 PM EDT

Prothena Corp Public (PRTA) Other Non-Current Liabilities (2014 - 2022)

Prothena Corp Public (PRTA) posted quarterly Other Non-Current Liabilities of $553000.0 for Q4 2022, little changed year-over-year from $553000.0 in Q4 2021, and little changed quarter-over-quarter from $553000.0 in Q3 2022.

Analysis

Prothena Corp Public (PRTA) Other Non-Current Liabilities (2014 - 2022) Analysis & Trends

Prothena Corp Public's Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $553000.0 for Q4 2022.

  • In Q4 2022, Other Non-Current Liabilities changed 0.0% year-over-year to $553000.0; the TTM figure through Dec 2022 stood at $553000.0 (changed 0.0% YoY), while the FY2022 annual figure was $553000.0, changed 0.0% from the prior year.
  • Other Non-Current Liabilities for Q4 2022 stood at $553000.0, roughly flat from $553000.0 in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $553000.0 in Q3 2018, with the low at $553000.0 in Q3 2018.
  • The 5-year median for Other Non-Current Liabilities is $553000.0 (2018), against an average of $553000.0.
  • Peak annual rise in Other Non-Current Liabilities reached 0.0% in 2019, while the deepest fall reached 0.0% in 2019.
  • Prothena Corp Public's Other Non-Current Liabilities stood at $553000.0 in 2018, then changed by 0.0% to $553000.0 in 2019, then changed by 0.0% to $553000.0 in 2020, then changed by 0.0% to $553000.0 in 2021, then changed by 0.0% to $553000.0 in 2022.
  • Business Quant data shows PRTA's Other Non-Current Liabilities at $553000.0 in Q4 2022, $553000.0 in Q3 2022, and $553000.0 in Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 Prothena Corp Public 509.98 Mn 221.78 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 553,000.00
Sep 30, 2022 553,000.00
Jun 30, 2022 553,000.00
Mar 31, 2022 553,000.00
Dec 31, 2021 553,000.00
Sep 30, 2021 553,000.00
Jun 30, 2021 553,000.00
Mar 31, 2021 553,000.00
Dec 31, 2020 553,000.00
Sep 30, 2020 553,000.00
Jun 30, 2020 553,000.00
Mar 31, 2020 553,000.00
Dec 31, 2019 553,000.00
Sep 30, 2019 553,000.00
Jun 30, 2019 553,000.00
Mar 31, 2019 553,000.00
Dec 31, 2018 553,000.00
Sep 30, 2018 553,000.00
Dec 31, 2016 98,000.00
Sep 30, 2016 98,000.00